Teva USA is #RemarkablyGeneric @accessiblemeds
Teva USA is #RemarkablyGeneric  @accessiblemeds
Uploaded May 2022 | Updated November 2026, 3 hours ago
As AAM journeys across the country with our Generics Are the Solution (GATS) tour, we pay a visit to Teva Pharmaceuticals USA, Inc. in Parsippany, NJ. The Teva team shares with us their commitment to patient access, safety, quality and affordability. “When a generic company wins a patent litigation, it's like David beating Goliath. The little guy wins. And what that translates to is lower healthcare costs for our patients” says Colman Ragan, Vice President & General Counsel, North America IP Litigation at Teva Pharmaceuticals.

To learn more about the generic and biosimilar medicines industry, visit accessiblemeds.org.
Teva USA is #RemarkablyGenericAAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel GoodeSavings from Biosimilars in 2021 #GRxBiosimsSavingsReportAAMs Christine Simmon Talks About Biosimilar Programming at GRx+Biosims 2019AAM Member Fresenius Kabi: Rachel GoodeCREATES Act - Its Time to Level the Playing FieldMark Cuban - AAM Access! 2023Protect & Expand CompetitionAAM Member Fresenius Kabi: Fabrice RomanetGeneric Drug Prices vs. Brand Drug PricesAAM All Access - Robert PollockJoin Us at Access! 2023 in Orlando, Florida
Association for Accessible Medicines |

Teva USA is #RemarkablyGeneric

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER